risperidone has been researched along with dextroamphetamine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 9 (50.00) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fletcher, PJ | 1 |
| Gruber, SH; Mathé, AA | 1 |
| Arnt, J; Didriksen, M; Pouzet, B | 1 |
| Gruber, SH; Mathé, AA; Nomikos, GG | 1 |
| Cowan, K; Dougherty, A; Grabowski, J; Hassan, S; Kopecky, C; Moeller, FG; Rhoades, H; Schmitz, J; Stotts, A | 1 |
| Aman, MG; Binder, C; Turgay, A | 1 |
| Benjamin, E; Salek, S | 1 |
| Carandang, C; Keshen, A | 1 |
| He, W; Li, M; Mead, A | 1 |
| Mahieu, M; Nordquist, RE; Pouzet, B; Schuurman, T; van der Staay, FJ | 1 |
| Casu, G; Deriu, A; Lazzari, P; Marchese, G; Pani, L; Peddio, G; Pira, M; Pisu, C; Pittau, B; Portesani, F; Spada, GP | 1 |
| Idris, NF; Marston, HM; McLean, SL; Neill, JC; Shahid, M; Wong, EH | 1 |
| Ball, SR; Bzdega, T; Der, EK; Farago, PR; Hark, TJ; Janczura, KJ; Lavin, KM; Lee, JC; Lee, MJ; Madore, JC; Neale, JH; Olszewski, RT; Profaci, CP | 1 |
| Rogóż, Z | 1 |
| Banks, ML; Hutsell, BA; Negus, SS | 1 |
1 review(s) available for risperidone and dextroamphetamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for risperidone and dextroamphetamine
| Article | Year |
|---|---|
Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.
Topics: Adolescent; Adult; Blood Pressure; Cocaine; Cocaine-Related Disorders; Cognitive Behavioral Therapy; Dextroamphetamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Heroin Dependence; HIV Infections; Humans; Male; Methadone; Middle Aged; Narcotics; Patient Dropouts; Psychiatric Status Rating Scales; Risperidone; Substance Abuse Detection | 2004 |
Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
Topics: Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Body Mass Index; Body Weight; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intelligence; Intelligence Tests; Male; Methylphenidate; Pemoline; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome | 2004 |
15 other study(ies) available for risperidone and dextroamphetamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
A comparison of the effects of risperidone, raclopride, and ritanserin on intravenous self-administration of d-amphetamine.
Topics: Animals; Behavior, Animal; Dextroamphetamine; Dopamine Antagonists; Injections, Intravenous; Male; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Serotonin; Reinforcement Schedule; Risperidone; Ritanserin; Salicylamides; Self Administration; Serotonin Antagonists | 1998 |
Effects of typical and atypical antipsychotics on neuropeptide Y in rat brain tissue and microdialysates from ventral striatum.
Topics: Animals; Antipsychotic Agents; Basal Ganglia; Dextroamphetamine; Haloperidol; Male; Microdialysis; Neuropeptide Y; Rats; Rats, Wistar; Risperidone; Sympathomimetics | 2000 |
Effects of the 5-HT(7) receptor antagonist SB-258741 in animal models for schizophrenia.
Topics: Animals; Antipsychotic Agents; Catalepsy; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Male; Motor Activity; Piperidines; Pyrrolidines; Rats; Rats, Wistar; Receptors, Serotonin; Reflex, Startle; Risperidone; Schizophrenia; Serotonin Antagonists; Social Behavior; Tosyl Compounds | 2002 |
Effects of haloperidol and risperidone on neurotensin levels in brain regions and neurotensin efflux in the ventral striatum of the rat.
Topics: Animals; Antipsychotic Agents; Basal Ganglia; Brain; Central Nervous System Stimulants; Dextroamphetamine; Dialysis Solutions; Haloperidol; Male; Microdialysis; Neurotensin; Rats; Rats, Wistar; Risperidone; Tissue Distribution | 2002 |
Stimulant-atypical antipsychotic interaction and acute dystonia.
Topics: Adolescent; Aggression; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Dystonic Disorders; Humans; Male; Methylphenidate; Risperidone; Substance Withdrawal Syndrome; Tourette Syndrome; Violence | 2005 |
Acute dystonic reaction in an adolescent on risperidone when a concomitant stimulant medication is discontinued.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Drug Administration Schedule; Dystonia; Humans; Male; Risperidone | 2007 |
Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Benzodiazepines; Conditioning, Psychological; Dextroamphetamine; Disease Models, Animal; Drug Interactions; Motivation; Motor Activity; Olanzapine; Phencyclidine; Rats; Rats, Sprague-Dawley; Risperidone; Schizophrenia; Schizophrenic Psychology | 2009 |
The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics.
Topics: Animals; Antipsychotic Agents; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Haloperidol; Hyperkinesis; Male; Risperidone; Swine; Swine, Miniature | 2009 |
A comparison of continuous subcutaneous paliperidone infusion and repeated subcutaneous injection of risperidone free-base in rats.
Topics: Animals; Antipsychotic Agents; Dextroamphetamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Administration Schedule; Infusions, Subcutaneous; Injections, Subcutaneous; Isoxazoles; Locomotion; Male; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone | 2010 |
Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Dextroamphetamine; Dibenzocycloheptenes; Drug Administration Schedule; Female; Hallucinogens; Heterocyclic Compounds, 4 or More Rings; Olanzapine; Phencyclidine; Rats; Rats, Inbred Strains; Reversal Learning; Risperidone | 2010 |
NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Exploratory Behavior; Glutamate Carboxypeptidase II; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Recognition, Psychology; Risperidone; Schizophrenia; Soman; Urea | 2012 |
Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice.
Topics: Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Dextroamphetamine; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hyperkinesis; Male; Mianserin; Mice; Mirtazapine; Motor Activity; Risperidone; Schizophrenia; Schizophrenic Psychology | 2012 |
Effects of 21-day d-amphetamine and risperidone treatment on cocaine vs food choice and extended-access cocaine intake in male rhesus monkeys.
Topics: Animals; Central Nervous System Stimulants; Choice Behavior; Cocaine; Dextroamphetamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Food; Macaca mulatta; Male; Risperidone; Self Administration | 2016 |